BRCA2 and ductal breast carcinoma in situ: Originally, a lower incidence of pure DCIS or DCIS accompanying invasive BC in BRCA1/BRCA2 PSV carriers was found compared with non-BRCA carriers/sporadic cases of BC [2–4].